CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my ...

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

"Our confidence in the near, medium and long-term outlook for CVS remains strong," the hedge fund said. Last week, CVS raised its 2025 profit forecast ... sees sales growth in third quarter ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all business segments.

CVS Health Corporation reported strong financial results for the first quarter of 2025, with revenues and earnings surpassing ...

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

CVS Health (NYSE:CVS) reported robust year-over-year growth in Q1 2025 earnings, with significant increases in sales, revenue ...

Retail sales of passenger vehicles (PV) grew 1.5% year-on-year to 3.5 lakh units in April 2025 compared with 3.44 lakh units ...

In fact, Lilly had just reported strong quarterly results driven by Zepbound’s growth, and there were no other negative developments disclosed. The CVS announcement, however, appears to have ...

medium and long-term outlook for CVS remains strong," the hedge fund said. Last week, CVS raised its 2025 profit forecast to $6 to $6.20 per share, from $5.75 to $6 projected previously.

"Our confidence in the near, medium and long-term outlook for CVS remains strong," the hedge fund said. Last week, CVS raised its 2025 profit forecast to $6 to $6.20 per share, from $5.75 to $6 ...